Sequoia Financial Advisors LLC Buys New Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Sequoia Financial Advisors LLC purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 74,814 shares of the real estate investment trust’s stock, valued at approximately $1,711,000.

Other hedge funds also recently added to or reduced their stakes in the company. Douglas Lane & Associates LLC purchased a new stake in shares of Healthpeak Properties in the third quarter worth about $33,947,000. Raymond James & Associates purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $25,711,000. Presima Securities ULC acquired a new position in Healthpeak Properties during the 3rd quarter worth approximately $22,465,000. AMF Tjanstepension AB purchased a new position in Healthpeak Properties in the 3rd quarter worth approximately $15,548,000. Finally, Handelsbanken Fonder AB acquired a new stake in Healthpeak Properties in the third quarter valued at approximately $11,668,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Down 0.6 %

DOC stock opened at $22.99 on Friday. The firm has a fifty day moving average price of $22.24 and a two-hundred day moving average price of $20.64. The company has a debt-to-equity ratio of 0.91, a current ratio of 0.70 and a quick ratio of 0.70. Healthpeak Properties, Inc. has a 1-year low of $15.24 and a 1-year high of $23.26. The firm has a market cap of $16.18 billion, a price-to-earnings ratio of 65.69, a PEG ratio of 2.27 and a beta of 1.14.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.23). Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The business had revenue of $695.50 million for the quarter, compared to analyst estimates of $665.11 million. During the same quarter last year, the company earned $0.45 EPS. Healthpeak Properties’s revenue was up 27.5% compared to the same quarter last year. Research analysts predict that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on DOC. Wells Fargo & Company reissued an “equal weight” rating and set a $23.00 target price (up from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. Wedbush boosted their price objective on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Scotiabank raised their target price on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research note on Monday, September 9th. Citigroup boosted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Finally, Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the company from $20.00 to $28.00 in a research note on Monday. One investment analyst has rated the stock with a sell rating, five have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.62.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.